Tuquib, Llyod L.

HRN: 27-79-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2025
CEFUROXIME 750MG (VIAL)
09/15/2025
09/22/2025
IV
750 MG
Q8HRS
MANDIBULAR FRACTURE
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines